Increased sweat chloride levels associated with prostaglandin E1 infusion.
D000015:Abnormalities, Multiple / Q000188:drug therapy; D000527:Alprostadil; D002712:Chlorides / Q000096:biosynthesis*; D003550:Cystic Fibrosis / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D008134:Long-Term Care; D008297:Male; D011458:Prostaglandins E / Q000009:adverse effects*; D013542:Sweat / Q000378:metabolism*; D013771:Tetralogy of Fallot / Q000188:drug therapy
D002712:Chlorides; D011458:Prostaglandins E; D000527:Alprostadil